Abstract
Our aim was to assess whether a higher clopidogrel maintenance dose has a greater antiplatelet effect in CYP2C19*2 allele carriers compared with noncarriers. Clopidogrel is a prodrug that is biotransformed by the cytochrome P450 enzymes CYP2C19, 2C9, and 3A4, 2B6, 1A2. The CYPC219*2 loss of function variant has been associated with a reduced antiplatelet response to clopidogrel and a 3-fold risk of stent thrombosis. Forty patients on standard maintenance dosage clopidogrel (75 mg), for 9.4 +/- 9.2 weeks, were enrolled into a dose escalation study. Platelet function was assessed at baseline and after 1 week of 150 mg once daily using the VerifyNow platelet function analyzer (Accumetrics Ltd., San Diego, California). Genomic DNA was hybridized to a BioFilmChip microarray on the INFINITI analyzer (AutoGenomics Inc., Carlsbad, California) and analyzed for the CYP19*2, *4, *17, and CYP2C9*2, *3 polymorphisms. Platelet inhibition increased over 1 week, mean +8.6 +/- 13.5% (p = 0.0003). Carriers of the CYP2C19*2 allele had significantly reduced platelet inhibition at baseline (median 18%, range 0% to 72%) compared with wildtype (wt) (median 59%, range 11% to 95%, p = 0.01) and at 1 week (p = 0.03). CYP2C19*2 allele carriers had an inc...Continue Reading
References
Aug 14, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·J GeigerU Walter
Nov 2, 2002·Journal of Cardiac Failure·Reginald F FryeArthur M Feldman
Nov 25, 2003·Clinical Chemistry·Shea Ping YipMaria L Wong
Nov 25, 2003·Clinical Chemistry·Larry J KrickaPaolo Fortina
Jan 7, 2004·Circulation·Wei C LauEric R Bates
Jan 18, 2005·Journal of the American College of Cardiology·Victor L SerebruanyEric J Topol
Jan 22, 2005·Nucleic Acids Research·Y Paul BaoUwe R Müller
May 7, 2005·PharmacoEconomics·William WeintraubMichel Bertrand
Jun 4, 2005·Stroke; a Journal of Cerebral Circulation·Sophie ZieglerChristine Mannhalter
Apr 29, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Dominick J AngiolilloCarlos Macaya
Aug 30, 2006·Journal of Thrombosis and Haemostasis : JTH·J W van WerkumJ M ten Berg
Mar 16, 2007·Clinical Pharmacology and Therapeutics·N A FaridD E Salazar
Aug 8, 2007·Thrombosis Research·Pierre FontanaFrançois Mach
Sep 29, 2007·Journal of Thrombosis and Haemostasis : JTH·J T BrandtK J Winters
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Nov 9, 2007·Circulation·Jeffrey L AndersonUNKNOWN Couma-Gen Investigators
Jan 22, 2008·Journal of the American College of Cardiology·Martine GilardJacques Boschat
Feb 5, 2008·Pharmacogenomics·Stuart A ScottRobert J Desnick
Feb 28, 2008·Journal of Clinical Pharmacology·David S SmallKenneth J Winters
Apr 2, 2008·Lancet·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Apr 5, 2008·Journal of the American College of Cardiology·Laurent BonelloFranck Paganelli
May 16, 2008·American Journal of Clinical Pathology·Cristi R KingCharles Eby
Sep 11, 2008·Pharmacogenomics·Tobias GeislerMatthias Schwab
Dec 17, 2008·American Heart Journal·Jolanta M Siller-MatulaBernd Jilma
Dec 25, 2008·The New England Journal of Medicine·Tabassome SimonUNKNOWN French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators
Dec 25, 2008·The New England Journal of Medicine·Jessica L MegaMarc S Sabatine
Dec 26, 2008·Lancet·Jean-Philippe ColletGilles Montalescot
Jan 9, 2009·Human Genomics·Huai-Ling HsuNuala A Helsby
Feb 6, 2009·European Heart Journal·Dirk SibbingNicolas von Beckerath
Mar 5, 2009·JAMA : the Journal of the American Medical Association·P Michael HoJohn S Rumsfeld
Mar 10, 2009·The American Journal of Cardiology·Betti GiustiGian Franco Gensini
Apr 1, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Wei C Lau, Paul A Gurbel
Apr 8, 2009·Thrombosis and Haemostasis·Dirk SibbingNicolas von Beckerath
Apr 14, 2009·Current Atherosclerosis Reports·Ali J Marian
May 26, 2009·JACC. Cardiovascular Interventions·Patrick GladdingMarja-Liisa Dahl
May 26, 2009·JACC. Cardiovascular Interventions·Patrick GladdingMarja-Liisa Dahl
Citations
Oct 28, 2010·JAMA : the Journal of the American Medical Association·Jessica L MegaMarc S Sabatine
Apr 13, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Vincent Lai Ming Yip, Munir Pirmohamed
Aug 2, 2011·European Heart Journal·Jeffrey J W VerschurenJ Wouter Jukema
Oct 13, 2010·Pharmacogenetics and Genomics·Katrin SangkuhlRuss B Altman
Apr 12, 2011·Thrombosis and Haemostasis·Liana YukhanyanKurt Huber
Sep 17, 2011·Circulation Research·Dan M RodenRussell A Wilke
Jun 17, 2010·Biomarkers in Medicine·Fabio Mangiacapra, Emanuele Barbato
Jul 16, 2015·Expert Opinion on Drug Metabolism & Toxicology·Yao YangStuart A Scott
Sep 3, 2011·Drug Discovery Today·Munir Pirmohamed
Oct 5, 2010·The Journal of Molecular Diagnostics : JMD·Victoria M PrattLisa Kalman
Oct 3, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·Jian-Min XiaoJia-Wu Song
Jul 16, 2015·CNS Neuroscience & Therapeutics·Yan HanJian-Feng Xu
Apr 23, 2013·BioMed Research International·Hyojin ChaeKiyuk Chang
Apr 23, 2011·JACC. Cardiovascular Interventions·Dimitrios AlexopoulosAglaia Athanassiadou
Mar 7, 2013·Genomics·Mick CorrellJuan B Grau
Mar 10, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Christine C LeeKiang-Teck J Yeo
Mar 4, 2014·Global Public Health·Catherine Olivier, Bryn Williams-Jones
May 24, 2016·Clinical and Translational Science·Meghan J ArwoodJulio D Duarte
Mar 1, 2014·Personalized Medicine·Taylor Sweezy, Shaker A Mousa
Nov 30, 2018·Acta Pharmacologica Sinica·Yi-Bei ChenMin Huang
Jun 29, 2016·Journal of Genetics·Xu LiuXuebo Liu
Jan 29, 2011·Clinical Pharmacology and Therapeutics·A L BeitelsheesA R Shuldiner
Nov 18, 2020·Pharmacology Research & Perspectives·Bhawani Yasassri AlvitigalaLiyanage Dona Ashanthi Menuka Arawwawala
Oct 11, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Nicola MarzilianoPiera Angelica Merlini